Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Denmark; International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet, University of Copenhagen, Denmark.
Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Denmark.
Int J Hyg Environ Health. 2020 Jan;223(1):93-105. doi: 10.1016/j.ijheh.2019.10.002. Epub 2019 Oct 25.
During the past two decades human exposure to bisphenol A (BPA) and phthalates such as di-iso-butyl phthalate (DiBP), di-n-butyl phthalate (DnBP), butylbenzyl phthalate (BBzP) and di-(2-ethyl-hexyl) phthalate (DEHP) has received substantial interest due to widespread population exposures and potential endocrine disrupting effects. Therefore, these chemicals have gradually been restricted and phased out through legislation. However, humans are still exposed to a wide range of other less studied phthalates, phthalate substitutes and BPA analogues as well as other polychlorinated and phenolic substances. In this study, we investigated human exposure to these chemicals over the past decade. Three hundred urine samples collected in 2009, 2013 and 2017 (100 samples each year) from young Danish men of the general population, participating in a large on-going cross-sectional study, were selected for the present time trend study. The urinary concentration of metabolites of 15 phthalates, di-2-ethylhexyl terephthalate (DEHTP) and di-iso-nonyl-cyclohexane-1,2-dicarboxylate (DINCH), seven bisphenols including BPA, bisphenol S (BPS) and bisphenol F (BPF), as well as triclosan, triclocarban, benzophenone-3, three chlorophenols and two phenylphenols were analyzed by two new sensitive LC-MS/MS methods developed and validated for the present study. A significant decrease in urinary concentrations over time was observed for the majority of the chemicals. Median concentrations of BPA and the metabolites of DiBP, DnBP, BBzP and DEHP were more than halved from 2009 to 2017. Similar decreases were observed for triclosan and the chloro- and phenylphenols. In contrast, metabolites of the two phthalate substitutes DEHTP and DINCH increased more than 20 and 2 times, respectively. The potential BPA substitutes; BPS and BPF also increased, but only slightly. Despite these new exposure patterns, the exposure to the old well-known chemicals, such as DiBP, DnBP, BBzP, DEHP and BPA was still higher in 2017 compared to the exposure level of the new substitutes such as DEHTP, DINCH, BPS and BPF. A significant decrease in internal exposure to most of the common phthalates and BPA over the past decade was observed, reflecting market changes and regulatory measures implemented in EU. Despite increasing exposures to some of the known phthalate substitutes and BPA analogues, the total amount of each measured chemical group (original and substitute analytes combined) was lower in the more recently collected samples. This indicates only partial direct substitution or substitution by chemicals not covered in this approach, or a general decline in the exposure to these chemical/product groups over the last decade.
在过去的二十年中,由于广泛的人群接触和潜在的内分泌干扰效应,双酚 A(BPA)和邻苯二甲酸酯(如邻苯二甲酸二异丁酯(DiBP)、邻苯二甲酸二正丁酯(DnBP)、邻苯二甲酸丁基苄基酯(BBzP)和邻苯二甲酸二(2-乙基己基)酯(DEHP))等物质的人类暴露引起了人们的极大关注。因此,这些化学物质已逐渐通过立法加以限制和逐步淘汰。然而,人类仍然接触到广泛的其他研究较少的邻苯二甲酸酯、邻苯二甲酸酯替代品和 BPA 类似物以及其他多氯和酚类物质。在这项研究中,我们研究了过去十年中人类对这些化学物质的暴露情况。从参加一项大型正在进行的横断面研究的丹麦年轻男性中,选择了 2009 年、2013 年和 2017 年(每年 100 份样本)收集的 300 份尿液样本,用于本时间趋势研究。通过两种新的、为本次研究开发和验证的灵敏 LC-MS/MS 方法,分析了 15 种邻苯二甲酸酯、邻苯二甲酸二(2-乙基己基)酯(DEHTP)和邻苯二甲酸二异壬基环己烷-1,2-二羧酸酯(DINCH)、7 种双酚(包括 BPA、双酚 S(BPS)和双酚 F(BPF))、三氯生、三氯卡班、二苯甲酮-3、三种氯酚和两种苯二酚的代谢物。观察到随着时间的推移,大多数化学物质的尿液浓度显著下降。2009 年至 2017 年间,BPA 及其代谢物、DiBP、DnBP、BBzP 和 DEHP 的中位数浓度减少了一半以上。三氯生和氯酚和苯二酚也观察到类似的下降。相比之下,两种邻苯二甲酸酯替代品 DEHTP 和 DINCH 的代谢物分别增加了 20 倍和 2 倍以上。潜在的 BPA 替代品 BPS 和 BPF 也有所增加,但只是略有增加。尽管出现了这些新的暴露模式,但 2017 年旧的、广为人知的化学物质(如 DiBP、DnBP、BBzP、DEHP 和 BPA)的暴露水平仍高于新替代品(如 DEHTP、DINCH、BPS 和 BPF)的暴露水平。在过去十年中,大多数常见的邻苯二甲酸酯和 BPA 的体内暴露量显著下降,这反映了欧盟市场变化和实施的监管措施。尽管一些已知的邻苯二甲酸酯替代品和 BPA 类似物的暴露量有所增加,但在最近采集的样本中,每个测量化学物质组(原始和替代分析物的组合)的总量要低。这表明只有部分直接替代或通过未在此方法中涵盖的化学物质进行替代,或者在过去十年中,这些化学物质/产品组的暴露总体下降。